Bini, C., Marcellusi, A., Mennini, F.S., Ripoli, S., Fioravanti, L., Paly, V.F., Molinari, A., Morelli, P., Krotneva, S. and Li, S. 2024. Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy. Global and Regional Health Technology Assessment. 11, 1 (Dec. 2024), 248–257. DOI:https://doi.org/10.33393/grhta.2024.3167.